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Edited by Masayuki MiyasakaAbstract Extracellular ATP is known to aﬀect the maturation
of monocyte-derived dendritic cells mainly by regulation of cyto-
kines and costimulatory molecules. The present study describes
the inhibition of MCP-1 (CCL2) and MIP-1a (CCL3) release
by human monocyte-derived dendritic cells in response to adenine
nucleotides. Our pharmacological data support the involvement
of P2Y11 and P2Y1 purinergic receptors in the downregulation
of these major monocyte recruiters. Migration assays have dem-
onstrated that supernatants of dendritic cells treated with ade-
nine nucleotides or anti-MCP-1/MIP-1a blocking antibodies
display a strongly reduced capacity to attract monocytes and
immature dendritic cells.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dendritic cell; Monocyte1. Introduction
Dendritic cells (DCs) are antigen-presenting cells, whose ma-
jor function is to initiate and regulate lymphocyte-mediated im-
mune responses. Maturing DCs migrate to draining lymph
nodes where they activate naı¨ve and memory T cells [1]. DCs
are a relevant source of chemokines [2]. At early stages of mat-
uration, DCs release high levels of MCP-1 (monocyte chemoat-
tractant protein-1; CCL2), MIP-1a (macrophage inﬂammatory
protein-1a; CCL3), MIP-1b (CCL4), IL-8 (CXCL8) and IP-10
(interferon-inducible protein 10; CXCL10) [3]. These inﬂam-
matory chemokines maintain the recruitment of circulating
immature DCs and T cells to inﬂamed tissue [4]. Immature
DCs constitutively release MDC (macrophage-derived chemo-
kine; CCL22) and TARC (thymus- and activation-regulated
chemokine; CCL17). These lymphoid chemokines are also re-
leased at later stages of DC maturation and constitute chemo-
tactic signals for mature DCs and T cells in secondary
lymphoid organs [5,6]. DC maturation is also accompaniedAbbreviations: LPS, lipopolysaccharide; MCP-1, monocyte chemoat-
tractant protein-1; MIP-1a, macrophage inﬂammatory protein-1a;
MoDCs, monocyte-derived dendritic cells; PGE2, prostaglandin E2
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doi:10.1016/j.febslet.2005.12.091by a shift in the expression of chemokine receptors: downregu-
lation of receptors for inﬂammatory chemokines such as
CCR1, CCR5 and CXCR1 and upregulation of receptors for
lymphoid chemokines such as CCR7 and CXCR4. Mature
DCs are then responsive to SDF-1 (stromal-derived factor-1;
CXCL12), MDC and MIP-3b (CCL19) chemokines and colo-
calise with naı¨ve T cells in secondary lymphoid organs [7].
In monocyte-derived DCs (MoDCs), ATP upregulates the
expression of costimulatory molecules but – in the presence
of lipopolysaccharide (LPS) – is able to downregulate IL-12
and upregulate IL-10 production [8–11]. These data support
the induction of a DC semi-mature state by extracellular
ATP. ADP downregulates both IL-10 and IL-12 production
induced by LPS in MoDCs [12]. In addition to these cytokine
regulations, a direct eﬀect of adenine nucleotides on DC che-
motaxis has also been reported [13,14]. While low concentra-
tions of ATP induced a recruitment of immature MoDCs,
high concentrations of ATP inhibited their migratory capacity
through P2Y11 activation [13–15].
In the present study, we demonstrated for the ﬁrst time that
adenine nucleotides regulate the recruitment of monocytes
through their action on DCs using an extensive RT-PCR
study, cytokine measurements and chemotaxis assays.2. Methods
2.1. Material
Leucomax and recombinant human GM-CSF were supplied by
Novartis (Basel, Switzerland). Recombinant human IL-4 and mono-
clonal anti-humanMCP-1 antibody were obtained from R&D Systems
(Abingdon, GB). ADP, ADPbS, ATP and ATPcS were purchased
from Sigma (St. Louis, MO). MRS-2179 was obtained from Tocris
Chemicals (Ellisville, MO). AR-C69931MX was a generous gift from
Drs. J.D. Turner and D. Shah (Astra Zeneca, Wilmington, DE). Pros-
taglandin E2 (PGE2) was purchased from Upjohn (MI, USA).
2.2. Preparation of monocytes and monocyte-derived dendritic cells
Immature human DCs were derived from adherent peripheral blood
monocytes of normal donors and cultured as previously described [12].
2.3. RT-PCR experiments
We designed speciﬁc primers for chemokines and chemokine recep-
tors that have been synthetised by Eurogentec (Seraing, Belgium) and
that are shown in Tables 1 and 2. Total RNAs were isolated using
RNeasy kit (Qiagen, Hilden, Germany) and reverse trancribed using
random hexamers and Superscript II Reverse Transcriptase (Invitro-
gen, Merelbeke, Belgium). PCR experiments were carried out usingblished by Elsevier B.V. All rights reserved.
Table 1
Speciﬁc primers for chemokines and GAPDH
Name Primer sequences (5 0 to 30) PCR product length Annealing temperature (C)
CCL2 MCP-1 agcagccaccttcattcc 236 55
tcggagtttgggtttgct
CCL3 MIP-1a cttgctgtcctcctctgc 200 51
cactcctcactggggtca
CCL5 RANTES cctcgctgtcatcctcat 198 53
ttcttctctgggttggca
CCL17 TARC gccccactgaagatgctg 216 53
cttgttgttggggtccga
CCL18 PARC gccctccttgtcctcgtc 145 53
ggatgacacctggcttgg
CCL22 MDC tcctggttgtcctcgtcc 165 50
ttagcaacaccacgccag
CXCL6 GCP2 tgctgccttatctttctg 232 50
tccttgctaactgctttca
CXCL7 NAP-2 cagacttgataccacccc 317 50
tcttgattctgggagcat
CXCL8 IL-8 gccaaggagtgctaaaga 198 50
tcagccctcttcaaaaac
CXCL10 IP-10 ttgacgctaagactaaac 253 53
catttccttgctaactgc
GADPH cggagtcaacggatttggtcgtat 306 58
agccttctccatggtggtgaagac
748 M. Horckmans et al. / FEBS Letters 580 (2006) 747–754Taq Polymerase (Invitrogen) according to the manufacturer’s instruc-
tions (30 cycles). RT-PCR data have been analysed using Quantity
One program (Bio-Rad, Hemel Hempstead, Herts, UK).2.4. ELISA
Human MCP-1 and MIP-1a levels were measured in DC superna-
tants by ELISA using commercially available kits from R&D Systems
(Abingdon, GB).
2.5. Chemotaxis assays
Chemotaxis assays for monocytes and immature DCs were per-
formed using 24-wells transwell chambers (pore size: 5 lm) (Costar,
Corning, NY). The lower chamber was ﬁlled with 500 ll of superna-
tant of DCs treated with or without 100 ng/ml LPS in combination
with adenine nucleotides (300 lM) in culture medium containing
0.5% serum. DC supernatants were treated during 18 h with or with-
out an anti-MCP-1 blocking and/or an anti-MIP-1a monoclonal anti-
body (3 lg/ml each). Monocytes or immature DCs (105 cells/well)
were resuspended in RPMI medium containing 0.5% serum to evalu-
ate the eﬀect of nucleotides on LPS-induced chemotaxis and wereTable 2
Speciﬁc primers for chemokine receptors
Name Primers sequences (5 0 to 30) P
CXCR1 gatgaagattacagcccc
ggaggtaacacgatgacg
CXCR4 atgggctcaggggactat
gatgaatgtccacctcgc
CCR1 gccagaaggtgaacgaga
cagccaggtccaaatgtc
CCR5 tggtcctgccgctgcttg
tgctccccagtggatcgg
CCR7 cgtgctggtggtggctct 1
aggtggtggtggtctcggthen placed into the upper chamber at 37 C for 3 h. Cells were then
harvested in the lower chamber, concentrated to 50 ll and counted.
Student’s t-test were performed using Prism software (GraphPad,
CA).3. Results
3.1. Extracellular adenine nucleotides regulate chemokine and
chemokine receptor mRNAs in human MoDCs
MoDCs were stimulated for 6 h with ATP (300 lM), ADP
(300 lM), their respective less hydrolysable derivatives ATPcS
and ADPbS (100 lM) and PGE2 (500 nM) – a known activa-
tor of DC maturation – to perform RT-PCR experiments with
speciﬁc primers for chemokine receptors and chemokines
(Figs. 1 and 2). Fig. 1 displays chemokines that were downreg-
ulated (A), upregulated (B) or not regulated (C) by adenine
nucleotides and PGE2. MCP-1, MIP-1a, GCP-2 (granulocyteCR product length Annealing temperature (C)
927 60
953 60
759 55
412 51
100 55
Fig. 1. Regulation of chemokine mRNA levels by adenine nucleotides and PGE2. DCs were stimulated for 6 h with 300 lM ATP, 300 lM ADP,
100 lM ATPcS, 100 lM ADPbS and 500 nM PGE2. Chemokine mRNAs were downregulated (A), upregulated (B) or not regulated (C). GAPDH
messenger levels were evaluated for each condition (D). Negative PCR control (NEG. CTRL) was performed for each couple of speciﬁc primers.
Fig. 2. Regulation of chemokine receptor mRNAs by adenine nucleotides and PGE2. DCs were stimulated for 6 h with 300 lMATP, 300 lMADP,
100 lM ATPcS, 100 lM ADPbS and 500 nM PGE2. Chemokine receptor mRNAs were downregulated (A) or upregulated (B). Negative PCR
control (NEG. CTRL) was performed for each couple of speciﬁc primers.
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downregulated by ATP and more strongly by thioderivatives
ATPcS and ADPbS (Fig. 1A). The eﬀect of ADP on chemo-
kine mRNA level was weaker than that of ATP and not signif-
icant on MIP-1a mRNA level (Fig. 1A). ATP and ADP both
upregulated IL-8 and NAP-2 (neutrophil activating peptide-2;
CXCL7) mRNA levels (Fig. 1B). On the contrary, TARC,
PARC (pulmonary and activation-regulated chemokine;
CCL18), MDC and RANTES (regulated upon activation, nor-
mal T-cell expressed and secreted; CCL5) were detected butnot signiﬁcantly regulated (Fig. 1C). All nucleotides – and
especially thioderivatives – induced a downregulation of
CCR5 and CXCR1 mRNAs (Fig. 2A) and an upregulation
of CXCR4 and CCR7 messengers (Fig. 2B). CCR1 mRNAs
were downregulated by ATP and ATPcS (Fig. 2A). PGE2 reg-
ulated chemokines and chemokine receptors mRNAs in a way
mostly comparable to that of ATP. Similar RT-PCR data have
been obtained for two independent preparations of DCs and
analysed using Quantity One program (Bio-Rad, Hemel
Hempstead, Herts, UK) (Figs. 3 and 4).
Fig. 3. Analysis of RT-PCR data for chemokines regulation. RT-PCR data have been obtained for two independent preparations of DCs and were
analysed using Quantity One program (Bio-Rad, Hemel Hempstead, Herts, UK). The analysis has been made for the chemokines that were
downregulated (A), upregulated (B) or not regulated (C). The data (means ± S.E.M.) have been normalised to GAPDH messenger level for each
condition.
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Fig. 4. Analysis of RT-PCR data for chemokine receptors regulation. RT-PCR data have been obtained for two independent preparations of DCs
and were analysed using Quantity One program (Bio-Rad, Hemel Hempstead, Herts, UK). The analysis has been made for the chemokine receptors
that were downregulated (A) or upregulated (B). The data (means ± S.E.M.) have been normalised to GAPDH messenger level for each condition.
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release by human DCs
We focused further study on newly identiﬁed regulations of
chemokines by adenine nucleotides. First, we conﬁrmed down-
regulation of MCP-1 and MIP-1a by adenine nucleotides at
the protein level by ELISA. In agreement with our RT-PCR
experiments, we observed downregulation of MCP-1 by both
ATP and ADP (Fig. 5A), and downregulation of MIP-1a only
by ATP (Fig. 5B). We also observed that suramin – a known
antagonist of P2Y11 and other P2 receptors [16] – prevented
downregulation of MCP-1 and MIP-1a mediated by ATP
(Fig. 5A and B). We have tested two inhibitors of ADP recep-
tors which are MRS-2179 – a speciﬁc antagonist of P2Y1 –
and AR-C69931MX which is an antagonist of both P2Y12
and P2Y13 receptors. Only MRS-2179 had an eﬀect on
ADP-mediated downregulation of MCP-1 release (Fig. 5A).
Suramin, MRS-2179 or AR-C69931MX alone did not aﬀect
MCP-1 or MIP-1a release (data not shown). On the other
hand, forskolin at 10 lM was able to reproduce the MCP-1
and MIP-1a downregulation observed in response to ATP,
suggesting the contribution of cAMP increase in these ATP-mediated chemokine downregulations. Since MCP-1 and
MIP-1a are known to be released in higher amounts in inﬂam-
matory conditions, we therefore performed comparable exper-
iments and obtained similar data in the presence of 100 ng/ml
LPS (Fig. 5C and D).
3.3. Adenine nucleotides reduce the capacity of DCs to attract
monocytes and other immature DCs
MCP-1 and MIP-1a are chemokines involved mainly in
monocyte and immature DC chemotaxis [17,18]. Therefore,
we tested whether adenine nucleotides could aﬀect the capacity
of DCs to regulate monocyte and immature DC chemotaxis
using Transwell migration assays. Supernatants of DCs treated
for 24 h with or without LPS 100 ng/ml in combination with
ATP (300 lM) or ADP (300 lM) were collected and placed
in the lower chamber. Supernatants of DCs treated with
ATP or ADP display a reduced capacity to attract monocytes
and immature DCs (Fig. 6A and B). Interestingly, signiﬁcant
reductions of monocyte and immature DC chemotaxis were
observed using supernatants of DCs treated with an anti-
MCP-1 (3 lg/ml) and/or an anti-MIP1a (3 lg/ml) blocking
Fig. 5. Regulation of MCP-1 and MIP-1a release by adenine nucleotides. DCs were treated for 24 h in the absence (A and B) or the presence (C and
D) of 100 ng/ml LPS with 300 lM ATP, 300 lM ATP plus 10 lM suramin, 300 lM ADP, 300 lM ADP plus 10 lM MRS-2179, 300 lM ADP plus
10 lMAR-C69931MX, 100 lMATPcS, 100 lMADPbS, or 10 lM forskolin. Supernatants were collected to perform ELISAs for MCP-1 (A and C)
and MIP-1a (B and D). The displayed data are the means ± S.D. of three (A, B) or two (C, D) independent experiments.
Fig. 6. Eﬀect of adenine nucleotides on the capacity of DCs to attract monocytes or immature DCs. The lower chamber was ﬁlled with 500 ll of
supernatant of untreated DCs (DC CTRL) or DCs treated for 24 h with or without 300 lMATP or 300 lMADP in the presence of 100 ng/ml LPS.
Supernatants of DCs treated with LPS alone (DC + LPS) were treated as indicated with or without anti-MCP-1 (3 lg/ml) and/or anti-MIP-1a (3 lg/
ml) blocking antibodies or with IgG1 control isotype antibody (3 lg/ml) (see Section 2). Monocytes (A) or immature DCs (B) were placed in the
upper chamber for 3 h. Data have been expressed in ratios between cells having migrated in the presence or the absence of stimulus and represent the
means ± S.E.M. of three independent experiments. Student’s t-test were performed using Prism software (GraphPad, CA) (*P < 0.05; **P < 0.01;
***P < 0.001; NS: not signiﬁcant).
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was observed using corresponding control isotype IgG1
(Fig. 6). ATP and ADP were not able to aﬀect the capacity
of DCs to recruit neutrophils in comparable migration assays
(data not shown).4. Discussion
ATP is known to modulate DC function directly via inter
alia a cAMP increase through P2Y11 activation [10,14], and
indirectly via its degradation product, ADP, through Gi-cou-
M. Horckmans et al. / FEBS Letters 580 (2006) 747–754 753pled receptors promoting ERK activation and calcium mobi-
lisation [12]. To study further how nucleotides could regulate
DC-leukocyte interactions, we have investigated the regula-
tions – initiated by ATP and ADP – of a large set of chemo-
kines and chemokine receptors. Similar mRNA regulations
were observed in response to adenine nucleotides and PGE2
which have comparable eﬀects on human DCs through
cAMP pathway. The regulations of chemokine receptors
(CXCR4, CCR7, CCR5) by ATP has been described previ-
ously [13] and are consistent with its positive eﬀect on DC
maturation. The eﬀects of ADP described in this study sup-
port the importance of ecto-nucleotidases such as CD39,
which is expressed on human DCs and hydrolyses ATP into
ADP [19].
Interestingly, we have observed that adenine nucleotides and
forskolin were able to downregulate MCP-1 and MIP-1a – two
well known monocyte and immature DC recruiters. No down-
regulation was still observed in the presence of suramin – an
antagonist the P2Y11 and other P2 receptors [16]. These data
support the involvement of P2Y11 – which is the only P2 recep-
tor coupled to the cAMP pathway and expressed in human
DCs [10,14]. The ADP eﬀects in human MoDCs are likely
mediated by one or many of the ADP receptors
[12,13,20,21]. The eﬀect of MRS-2179 on ADP-mediated
downregulation of MCP-1 release suggests an involvement of
P2Y1 receptor for ADP.
Downregulation of MCP-1 and MIP-1a release in response
to adenine nucleotides led us to focus the study on their poten-
tial regulation of DC-mediated leukocyte chemotaxis. We have
observed that supernatants of DCs treated with adenine nucle-
otides displayed a strongly reduced capacity to recruit mono-
cytes and immature DCs. Interestingly, ATP was able to
downregulate both MCP-1 and MIP-1a chemokines and we
have observed the strongest reduction of monocyte and imma-
ture DC migration using supernatants of DCs treated with the
combination of anti-MCP-1 and anti-MIP-1a blocking anti-
bodies.
Even if we focused functional studies on chemotaxis assays,
the regulation of MCP-1 and MIP-1a by extracellular nucleo-
tides could oﬀer other perspectives than the regulation of leu-
kocyte recruitment. These chemokines are indeed involved in
the regulation of other cell functions. MCP-1 is also a potent
activator of monocytes and MIP-1a was identiﬁed as a stem
cell inhibitor blocking the proliferation of hematopoietic pro-
genitor cells both in vitro and in vivo [18,22].
We have also observed downregulation of IP-10 by ATP and
ADP. This was already described for ATP, and correlated with
the reduced capacity of ATP-treated DCs to recruit Th1 and T
cytotoxic lymphocytes [15]. Moreover, we have observed
opposite eﬀects of adenine nucleotides on neutrophil recruiters.
There could be a balance between IL-8 and NAP-2 upregula-
tion and GCP-2 downregulation in response to adenine nucle-
otides. Anyway adenine nucleotides were not able to aﬀect the
capacity of DCs to recruit neutrophils.
In conclusion, the panel of regulations observed in the pres-
ent study oﬀers an overview of the regulation of chemotaxis
mediators by extracellular adenine nucleotides in human
MoDCs. More particularly, we have shown that extracellular
adenine nucleotides – through activation of P2 receptors ex-
pressed on DCs – downregulate the release of monocyte
recruiters and reduce their capacity to recruit monocytes and
immature DCs. At the site of inﬂammation, the release ofnucleotides could regulate recruitment and activation of
monocytes as well as the arrival of other immature DCs.
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